Company achieved FDA alignment on Phase 3 Oz-V trial for the treatment of 2L+ OPSCC, which will evaluate dual primary ...

Open-label prophylaxis data supporting the long-term safety profile and sustained benefits of deucrictibant, as well as clinical validation data of a kinin biomarker assay were highlighted in two oral ...

LIMERICK, Ireland, Nov. 12, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF) ("Kneat" or the "Company") a leader in digitizing and automating validation and quality processes, today ...

The Court held that Input Tax Credit cannot be denied due to a bona fide filing error in TRAN-1 and directed authorities to reopen the portal for resubmission within a ...

There comes a point in every company's journey when innovation stops being an idea and becomes infrastructure. SMX ...

Annualized recurring revenue ("ARR") of $838 million, an increase of 2% year-over-yearTotal revenue of $218 million, up 2% year-over-year; Product subscriptions revenue of $210 million, up 2% year-ove ...

CMS Reimbursement Codes -- The Centers for Medicare & Medicaid Services (CMS) approved dedicated CPT codes for superficial ...

NEW YORK, NY / ACCESS Newswire / November 7, 2025 / Every company reaches a turning point when its technology stops being promise and starts becoming structure. SMX (NASDAQ:SMX) is there now. The ...

Partnerships intend to make “proof” a currency across plastics, precious metals, textiles, and rare earth sectors NEW YORK, NY / ACCESS Newswire / November 5, 2025 / Some companies talk about traction ...

NEW YORK, NY / ACCESS Newswire / November 5, 2025 / Every generation reaches a point when progress demands proof. For Europe, following Singapore’s unprecedented action to usher in circularity, that ...

After years touting the amazing transparency of blockchains, the crypto community has started to realize that privacy is ...

Our Q3 2025 per share results reflect 32.0 million weighted average shares outstanding and include the effects of 3.4 million pre-funded warrant shares that were issued in April 2024 and February 2025 ...